Clinical trial
Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug
NCT00318747 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00318747 |
|---|---|
| Title | Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug |
| Official title | Asthma Immunotherapy With a Ragweed Allergen Immunostimulatory Sequence Conjugate |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Immune Tolerance Network (ITN) |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma, Allergy, Allergic Rhinitis, Rhinitis, Allergic, Seasonal |
| Intervention type | Drug |
| Interventions | Amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate (AIC) |
| Enrollment | 140 |
| Start date | Apr 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Apr 27, 2006 |
| Last update posted | Feb 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: